Skip to main content

Brachytherapy

Brachytherapy in Turkey

Brachytherapy in Turkey is internal radiation therapy that places a radioactive source inside or close to a planned treatment target. It may use temporary HDR or LDR sources, while selected treatments use permanent implants. Unlike external beam radiotherapy, the source is positioned within the body during treatment.

What Is Brachytherapy and How Does It Differ From External Radiation?

Brachytherapy treats cancer by placing radioactive material inside the body, directly within or close to the treatment target. External beam radiotherapy delivers radiation from a machine outside the patient's body. Brachytherapy instead positions the radiation source through an applicator, catheter, needle, seed, or another suitable device. This allows radiation delivery from a short distance to the planned tissue. The technique can be temporary or permanent, depending on the treatment approach. Brachytherapy does not describe one universal procedure. Source placement, dose rate, imaging, anesthesia, and treatment schedules vary according to cancer type and anatomy.

Oncology / Brachytherapy

Which Cancers Can Be Treated With Brachytherapy?

Brachytherapy can treat selected cancers when placing radiation inside or near the target has an established clinical role. Common applications include cervical, prostate, breast, head and neck, and selected eye cancers. Intracavitary treatment can place a source within an anatomical cavity near a tumor. This approach is used in selected gynecological cancers, including cervical and endometrial disease. Interstitial brachytherapy places radioactive sources directly within tissue. Prostate treatment represents one established example. Turkish public radiation oncology departments also document brachytherapy for gynecological tumors. Individual suitability depends on tumor location, stage, anatomy, previous treatment, and treatment objectives.

What Types of Brachytherapy Can Be Used?

Brachytherapy can use temporary or permanent radioactive sources, with dose delivery classified according to the selected treatment method.

  • HDR brachytherapy: A high-dose-rate source is temporarily positioned through an applicator and removed after radiation delivery.

  • LDR brachytherapy: A lower-dose-rate source can remain temporarily in position for a longer treatment period.

  • Permanent implants: Small radioactive sources remain inside the body while their radiation gradually decreases over time.

  • Intracavitary brachytherapy: The radioactive source is positioned within a body cavity near the planned treatment target.

  • Interstitial brachytherapy: Needles or catheters place radioactive sources directly within or around the target tissue.

The radiation oncologist selects the approach according to diagnosis, anatomy, treatment objective, and previous therapies.

What Happens Before and During Brachytherapy in Turkey?

Brachytherapy begins with clinical assessment, imaging, applicator planning, and dose calculation before radioactive material reaches the treatment area. The radiation oncologist first defines the treatment target and nearby structures requiring consideration. Depending on the procedure, an applicator, catheter, or needle is positioned near or within the target. Some procedures use anesthesia, sedation, or pain medication during placement. Imaging can then confirm applicator position and support treatment planning. A medical physicist calculates how the radioactive source should move or remain positioned. Temporary HDR sources are withdrawn when the planned radiation delivery is complete.

Why Is Imaging Important During Brachytherapy Planning?

Imaging helps define the treatment target, verify applicator position, and calculate radiation distribution around nearby organs. Brachytherapy places the radiation source very close to the intended treatment area. Small anatomical differences can therefore influence the relationship between the source and surrounding tissues. CT, MRI, ultrasound, or other imaging methods may support planning in appropriate cases. The selected modality depends on tumor location and the brachytherapy technique. Turkish public radiation oncology centers document three-dimensional brachytherapy planning systems. Imaging does not determine treatment suitability by itself. Radiation oncologists and medical physicists interpret anatomical information within the complete treatment plan.

Does Brachytherapy Make You Radioactive After Treatment?

Whether brachytherapy leaves radiation in the body depends on whether the radioactive source is temporary or permanent. After temporary HDR or LDR treatment, clinicians remove the radioactive source when treatment finishes. No brachytherapy radiation source remains after that removal. Permanent implants work differently because radioactive material stays inside the body. Their radiation becomes progressively weaker over time. Patients with permanent implants may receive temporary precautions regarding close contact with other people. Instructions can be particularly relevant around children or pregnant individuals. Patients should follow their treatment team's specific radiation-safety guidance rather than applying one rule to every brachytherapy technique.

Can Brachytherapy Be Combined With External Beam Radiation or Chemotherapy?

Yes, brachytherapy can form part of a combined cancer treatment plan when the diagnosis supports that approach. External beam radiation may treat a broader anatomical region before or alongside internal radiation treatment. Brachytherapy can then deliver additional radiation close to a defined target. Cervical cancer provides an established example where brachytherapy can accompany external beam radiotherapy. Chemotherapy may also form part of the treatment pathway in selected cancers. Other patients receive brachytherapy without concurrent systemic treatment. The sequence depends on pathology, stage, previous therapy, treatment objective, and individual health factors. Combined treatment requires coordinated oncology planning.

Which Brachytherapy Side Effects Require Clinical Monitoring?

Brachytherapy side effects depend mainly on the treated area, applicator placement, radiation dose, and surrounding healthy tissues.

  • Local tenderness: The catheter or applicator area can remain sore after temporary treatment devices are removed.

  • Urinary symptoms: Pelvic or prostate treatment can affect nearby urinary structures in some patients.

  • Bowel symptoms: Pelvic treatment can cause gastrointestinal effects when nearby bowel tissues receive radiation.

  • Sexual effects: Pelvic brachytherapy can influence sexual function or reproductive health in selected treatment settings.

  • Late effects: Some radiation-related complications can develop months or years after the original treatment course.

Patients should receive treatment-area-specific guidance because risks differ considerably between brachytherapy procedures.

What Does Turkey Regulate for Brachytherapy Services?

Turkey regulates brachytherapy equipment and clinical services within its current radiation oncology framework. The Radiation Oncology Services Regulation was published on December 16, 2025. It specifically lists brachytherapy treatment devices among regulated radiation oncology equipment. The framework also covers radioactive sources, treatment planning systems, dosimetry, staffing, licensing, and radiation protection. Radiation oncology centers must operate within applicable Ministry and Nuclear Regulatory Authority requirements. Public hospitals in Turkey document HDR brachytherapy equipment and three-dimensional planning services. These regulatory and technical facts do not guarantee individual treatment suitability, clinical results, or equivalent capabilities at every center.

What Should International Patients Prepare Before Brachytherapy in Turkey?

International patients should provide complete cancer and previous radiotherapy records before traveling for brachytherapy in Turkey. Pathology reports should document the confirmed diagnosis and clinically relevant tumor findings. Recent CT, MRI, PET-CT, or ultrasound records may support treatment review. Previous radiation plans are especially important when the proposed area has received earlier radiotherapy. Patients should provide delivered doses and treatment fields when available. Surgery, chemotherapy, and other systemic treatment records should also be included. The receiving team may request additional imaging before applicator planning. Follow-up and radiation-safety arrangements should be clarified before international travel begins.

How Can International Patients Verify a Brachytherapy Provider in Turkey?

International patients can verify health-tourism authorization through official records maintained by Turkey's Ministry of Health. The authorized provider page was updated on July 28, 2026. Authorization concerns eligibility to provide international health-tourism services. It does not confirm that every authorized provider offers brachytherapy. Patients should separately confirm the required radiation oncology service and brachytherapy technique. A May 2026 Ministry notice also established accreditation requirements for specified authorized facilities. Covered hospitals must complete TÜSKA accreditation requirements by December 31, 2026. Authorization or accreditation should not be interpreted as a treatment guarantee or individualized medical recommendation.

Brachytherapy in Turkey Cost 2026: What Affects the Total Cost?

Brachytherapy in Turkey has no single 2026 cost because treatment requirements vary according to the individual clinical pathway. This page therefore does not provide a fixed treatment price. Costs can depend on HDR, LDR, temporary, or permanent implant requirements. Imaging, applicator placement, anesthesia, treatment planning, and radioactive source use may also affect the financial plan. Some patients require external beam radiotherapy or additional cancer treatment alongside brachytherapy. Previous radiation can create further planning requirements. International patients should request an individualized written quotation after clinical assessment. It should identify included services, excluded services, planning, procedures, and follow-up arrangements.

This content provides general medical information and does not recommend a specific brachytherapy treatment, healthcare provider, or clinical outcome. Brachytherapy requires individual assessment by appropriately qualified healthcare professionals.

Last updated: August 14, 2026

Sources

  • https://www.cancer.gov/about-cancer/treatment/types/radiation-therapy/brachytherapy

  • https://www.cancer.gov/about-cancer/treatment/types/radiation-therapy

  • https://www.cancer.gov/about-cancer/treatment/types/radiation-therapy/side-effects

  • https://www.cancer.gov/types/cervical/hp/cervical-treatment-pdq

  • https://umraniyeah.saglik.gov.tr/TR-174708/radyasyon-onkolojisi.html

  • https://marmaraeah.saglik.gov.tr/TR-1393411/radyasyon-onkolojisi.html

  • https://antalyaism.saglik.gov.tr/TR-369921/radyasyon-onkolojisi-hizmetleri-yonetmeligi.html

  • https://shgmturizmdb.saglik.gov.tr/EN-69061/authorized-healthcare-providers-and-facilitators.html

  • https://shgmturizmdb.saglik.gov.tr/EN-108974/regulation-on-international-health-tourism-and-tourist-health.html

  • https://shgmturizmdb.saglik.gov.tr/TR-117812/saglik-turizmi-yetki-belgesine-sahip-saglik-tesislerinin-dikkatine.html

  • https://antalyaism.saglik.gov.tr/TR-366500/saglik-hizmetlerinde-tanitim-ve-bilgilendirme--faaliyetleri-hakkinda-yonetmelik.html